146
Views
4
CrossRef citations to date
0
Altmetric
Review

Precision medicine and personalized breast cancer: combination pertuzumab therapy

, , &
Pages 95-105 | Published online: 20 Mar 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ying Zhang, Shanshan Wu, Xinlei Zhuang, Gaoqi Weng, Jiansheng Fan, Xiaoyue Yang, Yingchun Xu, Liqiang Pan, Tingjun Hou, Zhan Zhou & Shuqing Chen. (2019) Identification of an Activating Mutation in the Extracellular Domain of HER2 Conferring Resistance to Pertuzumab. OncoTargets and Therapy 12, pages 11597-11608.
Read now

Articles from other publishers (3)

Ramesh K. Goyal & Geeta Aggarwal. 2022. Biomedical Translational Research. Biomedical Translational Research 123 140 .
Santosh Malik, Ananya Ghosh, Rout George Kerry & Jyoti Ranjan Rout. 2020. Advances in Pharmaceutical Biotechnology. Advances in Pharmaceutical Biotechnology 461 478 .
Dawei Jiang, Hyung-Jun Im, Haiyan Sun, Hector F. Valdovinos, Christopher G. England, Emily B. Ehlerding, Robert J. Nickles, Dong Soo Lee, Steve Y. Cho, Peng Huang & Weibo Cai. (2017) Radiolabeled pertuzumab for imaging of human epidermal growth factor receptor 2 expression in ovarian cancer. European Journal of Nuclear Medicine and Molecular Imaging 44:8, pages 1296-1305.
Crossref